Skip to main content
Log in

Photosensitivity Associated with Antipsychotics, Antidepressants and Anxiolytics

  • Review Articles
  • Pharmacoepidemiology
  • Published:
Drug Safety Aims and scope Submit manuscript

Summary

Photosensitivity reactions evoked by systemic agents are the result of the effects of the agent combined with subsequent exposure to light. Photosensitivity induced by exogenous parenteral agents accounts for an increasing portion of the total undesirable effects caused by environmental chemicals. The exponential increase in the number of new drugs introduced each year may be one of the factors explaining the increased number of reports describing photosensitivity induced by exogenous agents.

There are many reports of photosensitivity caused by antipsychotic and antidepressant agents. Although the majority of the research was focused on the photosensitising potential of chlorpromazine, other antipsychotics and antidepressants have been shown to cause cutaneous photosensitivity. An extensive drug history must be taken whenever a patient presents with a reaction limited to, or accentuated in, light-exposed areas. It should be remembered that these reactions may present with a wide morphological spectrum ranging from sunburn-like responses to eczematous, lichenoid and even bullous lesions, resembling porphyria cutanea tarda.

In order to properly diagnose photosensitivity to systemic drugs it is important to prove photosensitivity by phototesting and to rule out other causes of systemic photosensitivity such as systemic lupus erythematosus and porphyria cutanea tarda.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Srebrnik A, Hes J, Brenner S. Adverse cutaneous reactions to psychotropic drugsa. Acta Derm Venereol (Stockh): 1991; Suppl. 158: 3–12

    Google Scholar 

  2. Harth Y. Photosensitivity to systemic agents. In: DeLeo VA, editor. Photosensitivity diseases. Tokyo: Igaku-Shoin Medical Publishers Tokyo: Igaku-Shoin Medical Publishers, 1992: 56–83

    Google Scholar 

  3. Kochevar IE. Phototoxicity mechanisms: chlorpromazine photosensitized damage to DNA and cell membranes. J Invest Dermatol 1981; 77: 59–64

    Article  PubMed  CAS  Google Scholar 

  4. Kochevar IE. Mechanisms of drug photosensitivity. Photochern Photobiol 1987; 45: 891–5

    Article  CAS  Google Scholar 

  5. Harber LC, Bickers DR. Photosensitivity diseases. 2nd ed. Philadelphia: BC Decker, 1989; 16–202

    Google Scholar 

  6. Stern RB, Thibodeau LA, Kleinman RA, et al. Risk of cutaneous carcinoma in patients treated with oral methoxsalen photochemotherapy for psoriasis. N Engl J Med 1979; 300: 809–13

    Article  PubMed  CAS  Google Scholar 

  7. Baran R, Brun P. Photo-onycholysis induced by the fluoroquinolones pefloxacine and ofloxacine. Dermatologica 1986; 173: 185–8

    Article  PubMed  CAS  Google Scholar 

  8. Jeanmougin M, Morel P, Civatte J. Photo-onycholyse induit par la doxycycline. Ann Dermatol Veneorol 1982; 28: 53–4

    Google Scholar 

  9. Kestel JL. Photo-onycholysis from minocycline. Side effects of minocycline therapy. Cutis 1981; 28: 53–4

    PubMed  Google Scholar 

  10. Sanders CV, Saenz RE, Lopez M. Splinter hemorrhages and onycholysis: unusual reactions associated with tetracycline hydrochloride therapy. South Med J 1976; 69: 1090–2

    Article  PubMed  CAS  Google Scholar 

  11. Epstein JH. Phototoxicity and photoallergy. In: Pathak MA, editor. Sunlight and man. Tokyo: University of Tokyo Press, 1974; 459–77

    Google Scholar 

  12. Lever W, Schaumberg-Lever G. Histopathology of the skin. Philadelphia: Lippincott, 1990: 286

    Google Scholar 

  13. Abel EA, Farber EM. Photochemotherapy. In: Rook AF, editor. Recent advances in dermatology. Edinburgh: Churchill-Livingstone, 1980: 259–83

    Google Scholar 

  14. Rosenthal I, Ben-Hur E, Prager A, et al. Photochemical reactions of chlorpromazine: chemical and biochemical implications. Photochem Photobiol 1978; 28: 591–4

    Article  PubMed  CAS  Google Scholar 

  15. West AJ, Berger TG, LeBoit PE. A comparative histopathologic study of photodistributed and non photodistributed lichenoid drug eruptions. J Am Acad Dermatol 1990; 23: 689–93

    Article  PubMed  CAS  Google Scholar 

  16. Morison WL, Kochevar IE. Photoallergy. In: Parrish JA, Kripke ML, Morison WL, editors. Photoimmunology. New York: Plenum, 1983

    Google Scholar 

  17. Emmett AE. Diphenhydramine photoallergy. Arch Dermatol 1974; 110: 249–52

    Article  PubMed  CAS  Google Scholar 

  18. Guidici PA, Maguire HC. Experimental photoallergy to systemic drugs. J Invest Dermatol 1985; 85: 207–11

    Article  Google Scholar 

  19. Epstein S. Photoallergy versus phototoxicity. In: Dermatoses due to environmental and physical factors. Springfield: Thomas, 1962: 119–35

    Google Scholar 

  20. Lever W, Schaumberg-Lever G. Histopathology of the skin. Philadelphia: Lippincott, 1990; 107

    Google Scholar 

  21. Schutz, et al. Arch Klin Exp Dermatol 1956; 202: 285

    Google Scholar 

  22. Epstein FH, Brunsting LA, Peterson MC, et al. A study of photosensitivity occurring with chlorpromazine therapy. J Invest Dermatol 1957; 28: 329–38

    PubMed  CAS  Google Scholar 

  23. Ayd JF. The dermatologic and systemic manifestations of chlorpromazine hypersensitivity. J Nerv Ment Dis 1956; 124: 84–7

    Article  PubMed  Google Scholar 

  24. Calnan CD, Frain-Bell W, Cuthbert JW. Occupational dermatitis from chlorpromazine. Trans St Johns Hosp Dermatol Soc 1962; 48: 49–70

    PubMed  CAS  Google Scholar 

  25. Epstein S. Chlorpromazine photosensitivity. Arch Dermatol 1968; 98: 354–63

    Article  PubMed  CAS  Google Scholar 

  26. Hays GB, Lyle CB, Wheeler CE. Slate-gray color in patients receiving chlorpromazine. Arch Dermatol 1964; 90: 471–6

    Article  PubMed  CAS  Google Scholar 

  27. Hashimoto K, Wiener W, Albert J, et al. An electron microscopi study of chlorpromazine pigmentation. J Invest Dermatol 1966; 47: 296–306

    PubMed  CAS  Google Scholar 

  28. Blois MS. On chlorpromazine binding in vivo. J Invest Dermatol 1965; 45475–481

    Google Scholar 

  29. Palidavskey GP, Hashimoto K, Heller GL, et al. Chlorpromazine induced lupus like disease: case report and review of the literature. J Am Acad Dermatol 1985; 13: 109–15

    Article  Google Scholar 

  30. Flor-Alberti AJ. Chlorpromazine-induced lupus-like illness. Am Fam Physician 1983; 27: 151–2

    Google Scholar 

  31. Hashimoto K, Nizuma K. Skin pathology by light and electron microscopy. New York: Igaku-Shoin Medical Publishers, Inc. 1983: 82

    Google Scholar 

  32. Satanove A, Mclntosh JS. Phototoxic reactions induced by high dosages of chlorpromazine and thioridazine. JAMA 1967; 200: 209–12

    Article  PubMed  CAS  Google Scholar 

  33. Gammon WR, Caro I, Long JC, et al. Secondary cutaneous mucinosis with systemic lupus erythematosus: a case presentation and review of the literature. Arch Dermatol 1978; 114: 432–5

    Article  PubMed  CAS  Google Scholar 

  34. Magnus UA. Dermatological photobiology. Clinical and experimental aspects. Oxford: Blackwell, 1976

    Google Scholar 

  35. Photosensitivity from drugs, perfumes and cosmetics. Med Lett Drugs Ther 1980; 22: 64

    Google Scholar 

  36. Basier RS, Goetz CS. Synergism of minocycline and amitriptyline in cutaneous hyperpigmentation [letter]. J Am Acad Dermatol 1985; 12: 577

    Google Scholar 

  37. Basier RSW, Kohnen PW. Localized hemosiderosis as a sequella of acne. Arch Dermatol 1978; 114: 1695–7

    Article  Google Scholar 

  38. Walter-Ryan WG, Kern III EE, Shirriff JR, et al. Persistent photoaggravated cutaneous eruption induced by imipramine. JAMA 1985; 357–8

    Google Scholar 

  39. Hare PJ. ‘Visage Mauve’ (from imipramine?). Br J Dermatol 1970; 83: 420

    Article  PubMed  CAS  Google Scholar 

  40. Torras H, Mascaro Jr JM, Mascaro JM. Photo-onycholysis caused by clorazepate dipotassium. J Am Acad Dermatol 1989; 21: 1304–5

    Article  PubMed  CAS  Google Scholar 

  41. Kanwar AJ, Gupta R, Das Mehta S, et al. Photosensitivity to alprazolam [letter]. Dermatologica 1990; 181: 75

    Article  PubMed  CAS  Google Scholar 

  42. Luton EF, Finchum RN. Photosensitivity reaction to chlordiazepoxide. Arch Dermatol 1965; 91: 362–3

    Article  Google Scholar 

  43. Davis JM. Minor tranquilizers, sedatives and hypnotics. In: Kaplan HI, Sadock BJ, editors. Comprehensive textbook of psychiatry. Baltimore: Williams & Wilkins, 1985; 1537–53

    Google Scholar 

  44. Hicks JH. ‘Lupus erythematosus-like’ syndrome from chlordiazepoxide. Cutis 1973; 11: 33–8

    Google Scholar 

  45. Bakri A, Van Henegouwen GB, Chanel JL. Involvement of the N4-oxide group in the phototoxicity of chlordiazepoxide in the rat. Photodermatol 1985; 2: 205–12

    PubMed  CAS  Google Scholar 

  46. Epstein JH, Wintroub BU. Photosensitivity due to drugs. Drugs 1985; 30: 42–57

    Article  PubMed  CAS  Google Scholar 

  47. Toback AC, Anders JE. Phototoxicity from systemic agents. In: DeLeo VA, editor. Photosensitivity diseases. Dermatol Clin 1986; 4: 223–30

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Harth, Y., Rapoport, M. Photosensitivity Associated with Antipsychotics, Antidepressants and Anxiolytics. Drug-Safety 14, 252–259 (1996). https://doi.org/10.2165/00002018-199614040-00005

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00002018-199614040-00005

Keywords

Navigation